Carisma Therapeutics, Inc. (CARM)

Carisma Therapeutics Revenue

Carisma Therapeutics had revenue of $45.25M in the quarter ending September 30, 2025, with 1,236.78% growth. This brings the company's revenue in the last twelve months to $52.63M, up 159.68% year-over-year. In the year 2024, Carisma Therapeutics had annual revenue of $19.63M with 31.59% growth.

• Revenue (ttm): 52.63M
• Revenue Growth: +159.68%
• P/S Ratio: 0.00
• Revenue / Employee: 1.14M
• Employees: 46
• Market Cap: 4.19K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	19.63M	4.71M	31.59%
Dec 31, 2023	14.92M	5.09M	51.71%
Dec 31, 2022	9.83M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error